GlassScriptPhysician profile
Cameron C Chin
NPI 1912474495
$2,831.73
in general payments reported to CMS, 2019-2025
32 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,082 · 2022: $1,036 · 2023: $332 · 2024: $208 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $713.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $686.83 | 2021-2025 | |
| Pfizer INC. | $217.69 | 2022-2024 | |
| Amgen INC. | $202.80 | 2021-2023 | Repatha |
| Abbott Laboratories | $190.75 | 2024-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Tacticath Ablation Catheter, Sensor Enabled, Aveir |
| Merck Sharp & Dohme LLC | $157.67 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $152.15 | 2021-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.63 | 2021-2022 | |
| Heartflow, INC. | $107.18 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $102.35 | 2021-2025 | Lifevest |
| Amarin Pharma, INC. | $93.35 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $85.05 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $76.98 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $76.22 | 2021-2022 | |
| Boston Scientific Corporation | $71.71 | 2023-2024 | Avvigo Guidance System, Opticross, Emblem Mri S-Icd |
| Abbvie INC. | $63.02 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $58.21 | 2021 | |
| Atricure, INC. | $50.33 | 2022 | |
| Novo Nordisk INC | $41.38 | 2021-2022 | |
| Avanir Pharmaceuticals, INC. | $30.21 | 2022 | |
| Edwards Lifesciences Corporation | $27.15 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| E.R. Squibb & Sons, L.L.C. | $24.13 | 2022 | |
| Alnylam Pharmaceuticals INC. | $22.71 | 2022 | |
| Eisai INC. | $21.72 | 2021 | |
| Inari Medical, INC. | $21.39 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Dexcom, INC. | $18.96 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.96 | 2021 | |
| Angiodynamics, INC. | $15.38 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.88 | 2022 | |
| United Therapeutics Corporation | $14.73 | 2021 | |
| Kestra Medical Technology Services, INC. | $14.41 | 2025 | Assure Wcd |
| Cvrx, INC. | $13.53 | 2024 | Barostim Neo System |
| G Medical Diagnostic Services, INC. | $12.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Chin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.